Table 2.
Comparison of T-SPECT results in breast cancer patients that either received (Yes) or not (No) cardiotoxic adjuvant chemotherapy.
| MPI | Left Breast Cancer |
Right Breast Cancer |
All Breast Cancer |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Yes | No | p | Yes | No | p | Yes | No | p | |
| SSS | 2.9 ± 3.5 | 4.7 ± 3.5 | 0.34 | 5.2 ± 2.4 | 3.1 ± 3.1 | 0.31 | 3.6 ± 3.3 | 4.0 ± 3.4 | 0.83 |
| SRS | 1.2 ± 1.9 | 2.0 ± 2.6 | 0.46 | 1.2 ± 1.6 | 0.6 ± 0.6 | 0.32 | 1.2 ± 1.7 | 1.4 ± 2.1 | 0.97 |
| ASSS | 1.8 ± 3.6 | 3.1 ± 3.4 | 0.45 | 3.6 ± 0.5 | 1.1 ± 1.3 | 0.32 | 2.4 ± 3.1 | 2.2 ± 2.8 | 0.74 |
| S-RSS | 1.7 ± 1.9 | 2.6 ± 2.6 | 0.40 | 4.0 ± 3.5 | 2.5 ± 2.7 | 0.60 | 2.4 ± 2.6 | 2.6 ± 2.6 | 0.79 |
Cardiotoxic chemotherapy included Adriamycin in 2 patients and Epirubicin in 14 patients; MPI: myocardial perfusion imaging; SSS: summed stress score; SRS: summed rest score; ASSS: anterior wall stress score; S-RSS: the difference of SSS minus the SRS.